RT Book, Section
A1 Bizekis, Costas S.
A1 Zervos, Michael D.
A1 Pass, Harvey I.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Colson, Yolonda L.
A2 Jaklitsch, Michael T.
A2 Krasna, Mark J.
A2 Mentzer, Steven J.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1105845229
T1 Thoracoscopy with Intrapleural Sclerosis for Malignant Pleural Effusion
T2 Adult Chest Surgery, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-178189-3
LK accesssurgery.mhmedical.com/content.aspx?aid=1105845229
RD 2024/04/24
AB Malignant  pleural  effusion  is  a  common  clinical  problem  in  neoplastic  diseases.  Approximately  half  of  all  patients  with  metastatic  cancer  develop  a  malignant  pleural  effusion  as  a  consequence  of  their  disease.1  Although  there  have  been  no  epidemiologic  studies,  the  annual  incidence  of  malignant  pleural  effusion  in  the  United  States  is  estimated  to  be  more  than  200,000  cases.2  The  main  problem  that  patients  who  develop  such  effusions  experience  is  a  reduction  in  the  quality  of  life  owing  to  symptoms  such  as  dyspnea,  chest  pain  (primarily  related  to  involvement  of  the  parietal  pleura  and  chest  wall),  and  cough.2